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and secondary hyperparathyroidism: Report
of cases and review of the literatureFaissal Tarrass a,*, Samira Daki a, Meryem Benjelloun a,
Benyounes Ramdani a, Mohamed Garbi Benghanem a,
Driss Zaid a, Saida Sqalli ba Departement Nephrology, Ibn Rochd Hospital, 20450 Casablanca, Morocco
b Histo-Pathology laboratory, Ibn Rochd Hospital, 20450 Casablanca, MoroccoReceived 2 January 2005; accepted 22 January 2005Summary Papillary thyroid carcinoma (PTC) is known to occur in association with
primary hyperparathyroidism (HPT). A combination of secondary HPT and PTC is a
rare event, and of pathogenetic interest. We report two long-term hemodialysis
patients in whom invasive PTC was diagnosed at the time of parathyroidectomy
for a medically uncontrolled HPT. We suggest that the association of simultaneous
pathology of the thyroid and parathyroid glands should be always considered in ure-
mic patients with secondary HPT. A common oncogenic stimulus may have been
involved.c 2005 Elsevier Ltd. All rights reserved.
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dIntroduction
Papillary thyroid carcinoma (PTC) is the most com-
mon form of thyroid cancer, which usually remains
clinically silent until its incidental histologic diag-
nosis in autopsy or surgical material.1 In primary
hyperparathyroidism, PTC have been well de-
scribed. 2 Although, in secondary hyperparathy-
roidism (HPT), isolated cases have been reported741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reser
oi:10.1016/j.ooe.2005.01.001
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here two cases of thyroid cancer diagnosed at the
time of parathyroidectomy for secondary HPT in
patients with end-stage renal disease (ESRD).Case reports
Patient IA 53 years old male, with no personal or family his-
tory of neck irradiation, thyroid cancer, or multipleved.
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parathroidectomy because of medically uncon-
trolled HPT. The patient had developed ESRD sec-
ondary to chronic glomerulonephritis, and had
been established on hemodialysis for 119 months
at the time of admission. A skeletal survey per-
formed two months previously had shown calcifica-
tion of the medical sclerosis type affecting arteries
of the feet, hands, forearms and pelvis. Investiga-
tion showed elevated alkaline phosphatase 1872
iu/l (70–300), grossly elevated PTH 1759 pg/ml
(10–75), serum calcium 78 mg/l (85–104), and
phosphorus 55 mg/l (25–48). The findings of chest
radiography and neck ultrasonography were nor-
mal. During the surgical exploration of the neck,
two parathyroid glands on the right were in-
spected, and the biopsy findings appeared normal.
The upper left parathyroid gland was resected
after intraoperative biopsy suggested hyperplasia.
The fourth gland could not be prepared. The final
histologic analysis of the resected parathyroid
gland confirmed hyperplasia. The thyroid gland
had a focus of follicular variant of PTC with a max-
imum diameter of 0.7 cm (Fig. 1). No palpable cer-
vical lymph nodes were discovered at meticulous
intraoperative exploration of the region. Postoper-
ative PTH level was 10 pg/ml. Checkups for possi-
ble tumor propagation including chest X ray, bone
scintigraphy, neck ultrasonography, and scintigra-Figure 1 Follicular variant of papillary thyroid carci-
noma with vesicular nuclei, and hemorrhage in follicular
lumens (light microscopy, original magnification · 20).phy, have been found to be negative. The patient
was given oral thyroid hormone replacement ther-
apy (thyroxine, T4; 100 mg/day). During the sixth
and 12th postoperative months a total body scan
demonstrated no evidence of any metastatic focus.
Chest radiographs and serum calcium and phospho-
rus levels remained within normal ranges at regular
follow-up visits at 6, 12, 18, and 24 months
postoperatively.
Patient IIA 25 years old female with a history of ESRD sec-
ondary to chronic pyelonephritis and congenital
urogenital malformations, on long-term hemodialy-
sis for 90 months. Nine months prior to her admis-
sion, she had biochemical evidence of HPT.
Laboratory investigation demonstrated hypocalce-
mia (82 mg/l), hyperphosphatemia (52 mg/l), with
a peak PTH level of 1716 pg/ml. Neck ultrasonogra-
phy was normal. Surgical parathyroidectomy was
indicated, because HPT failed to respond to medi-
cal therapy comprising alfacalcidol and calcium
carbonate. The histological report diagnosed
hyperplasia of the parathyroid glands, with a small,
non-encapsulated sclerosing PTC (diame-
ter = 0.8 cm). Regional lymph nodes were not af-
fected. The patient’s postoperative course was
uneventful, normocalcemia was achieved immedi-
ately after parathyroidectomy. Regular check ups
have not verified any recurrences or metastases.
The patient has remained free of HPT and thyroid
cancer during a follow-up period of 3 years.Discussion
A higher incidence of certains types of malignancy
has been reported in patients with parathyroid ade-
nomas. Specifically, an association between pri-
mary HPT and PTC has been frequently reported.2
In addition, there have been few reports of PTC
in patient with secondary HPT,3–6 and its has been
sugested that the incidence of malignancy is higher
in patients with renal failure than in general popu-
lation.7,8 Thyroid carcinoma has been reported in
patients with renal failure both before and after
transplantation.9 Frequent reports regarding the
copresentation of primary HPT and thyroid carci-
noma have prompted speculation of the etiology
of this association. However, because primary
and secondary HPT are entirely different diseases,
the implications of the coassociation between thy-
roid carcinoma and secondary HPT have been
pointed in different etiologic direction, including
76 F. Tarrass et al.the incidental detection of occult malignancy at
the time of parathyroidectomy.10
Thyroid cancer was found in 36% of 11 ESRD pa-
tients from japan with secondary HPT, compared
with 11% in an autopsy control group (p\0.05).3
Various explanations have been proposed for the
increased cancer incidence in ESRD. However, the
pathogenetic mechanism have not been fully eluci-
dated as yet. Several factors directly or indirectly
associated with the renal failure and the therapeu-
tic regimens applied in the management of these
patients may favour malignant transformation and
tumor formation. A potential involvement of PTH
excess in the enhenced carcinogenesis of these pa-
tients has to be discussed. At the cellular level PTH
was shown to increase proliferation in the bone
marrow and liver in vivo and in T-lymphocytes in vi-
tro. In contrast, the active form of vitamin D 1,25-
dihydroxycholecalciferol appears to suppress cell
proliferation and promote differentiation of imma-
ture or neoplastic cells. Hence, the pro-tumor ac-
tion of excess PTH may act unopposed due to the
deficiency of 1,25-dihydroxycholecalciferol in
chronic renal failure contributing to increased tu-
mor formation.11
Immunologic surveillance is generally accepted
as a major defense against neoplastic cells, how-
ever, uremic patients are considered to be in a
state of reduced immunocapacity. Therfore, the
incidence of thyroid carcinoma might be high in
those patients for this reason.3,11
Previous neck irradiation, although not present
in our patient, appears to increase the risk for thy-
roid cancer.11 In addition, various factors, such as
the goitrogenic effects of calcium and excessive
production of calcitonine in response to hypercal-
cemia have been proposed as a common patho-
genic mechanism for the coexistence of thyroid
carcinoma and HPT. Taylor12 theorized that cal-
cium carbonate has a goitrogenic effect either by
inhibiting the synthesis of thyroxine or by increas-
ing iodine clearance by the kidney, and Ellenberg
et al.13 reported that hypercalcemia also might
be carcinogenic.Since, occult PTC is an occasional incidental
finding during surgery for HPT, careful palpation
and inspection of the entire thyroid gland at the
time of open parathyroid resection is higly
recommended.14References
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